{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T23:41:05Z","timestamp":1780530065000,"version":"3.54.1"},"reference-count":51,"publisher":"Knowledge E DMCC","issue":"5","content-domain":{"domain":["knepublishing.com"],"crossmark-restriction":true},"short-container-title":["IJRM"],"abstract":"<jats:p>Background: Biochemical markers including interleukins (ILs) has been proposed for early diagnosis of asphyxia. Objective: This study has aimed to systematically review the significance of IL measurements in the diagnosis of perinatal asphyxia.\r\n Materials and Methods: PubMed, Cochrane Library, Web of Science, Embase, and Scopus databases before 2017 were searched for the following keywords: asphyxia, neonatal, interleukin, and diagnosis. A total of 13 out of 300 searched papers were finally selected for evaluation. Interleukins under study were IL6 and interleukin 1\u03b2 (IL-1\u03b2). Interleukins had been measured in 10 studies by serum samples, 2 studies by samples of Cerebro Spinal Fluid (CSF), and 1 study by sample of umbilical cord blood. The inclusion criteria were: studies on neonates, with adequate information from the test results and studies using markers other than ILs to detect asphyxia; however, studies with only abstracts available were excluded.\r\nResults: Research on the issue suggests that IL6 &gt; 41 Pg\/dl has the sensitivity of 84.88% and the specificity of 85.43%, whereas IL-1\u03b2 &gt; 4.7 Pg\/dl has the sensitivity of 78% and specificity of 83% in the diagnosis of neonatal asphyxia. Among diagnostic ILs for neonatal asphyxia, combination of IL6 and IL-1\u03b2 had the highest sensitivity, that is, 92.9%.\r\n Conclusion: IL6 and IL-1\u03b2 of serum samples were used in the early diagnosis of perinatal asphyxia and are useful predictors for the outcomes of perinatal asphyxia and its intensity. In addition, simultaneous evaluation of IL-1\u03b2 and IL6 can improve the sensitivity of the early diagnosis of perinatal asphyxia.<\/jats:p>","DOI":"10.18502\/ijrm.v17i5.4598","type":"journal-article","created":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T05:29:41Z","timestamp":1562045381000},"page":"303-314","update-policy":"https:\/\/doi.org\/10.18502\/knecrossmarkpolicy","source":"Crossref","is-referenced-by-count":6,"title":["Interleukins in diagnosis of perinatal asphyxia: A systematic review"],"prefix":"10.18502","volume":"17","author":[{"given":"Hassan","family":"Boskabadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Moradi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Zakerihamidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7770","published-online":{"date-parts":[[2019,6,18]]},"reference":[{"key":"21358","unstructured":"Boskabadi H, Tavakol Afshari J, Ghayour-Mobarhan M, Maamouri G, Shakeri MT, Sahebkar A, et al. Association"},{"key":"21359","doi-asserted-by":"crossref","unstructured":"between serum interleukin-6 levels and severity of perinatal asphyxia. Asian Biomedicine 2010; 4: 79\u201385.","DOI":"10.2478\/abm-2010-0009"},{"key":"21360","unstructured":"Boskabadi H, Zakerihamidi M, Sadeghian MH, Avan A, Ghayour-Mobarhan M, Ferns GA. Nucleated red blood"},{"key":"21361","unstructured":"cells count as a prognostic biomarker in predicting the complications of asphyxia in neonates. J Matern Fetal"},{"key":"21362","doi-asserted-by":"crossref","unstructured":"Neonatal Med 2017; 30: 2551\u20132556.","DOI":"10.1080\/14767058.2016.1256988"},{"key":"21363","doi-asserted-by":"crossref","unstructured":"Boskabadi H, Ashrafzadeh F, Doosti H, Zakerihamidi M. Assessment of risk factors and prognosis in asphyxiated infants. Iran J Pediatr 2015; 25: e2006.","DOI":"10.5812\/ijp.2006"},{"key":"21364","unstructured":"Costello AM, Manandhar DS. Perinatal asphyxia in less developed countries. Arch Dis Child Fetal Neonatal Ed"},{"key":"21365","unstructured":"; 71: F1\u2013F3."},{"key":"21366","unstructured":"Dixon G, Badawi N, Kurinczuk JJ, Keogh JM, Silburn SR, Zubrick SR, et al. Early developmental outcomes after"},{"key":"21367","doi-asserted-by":"crossref","unstructured":"newborn encephalopathy. Pediatrics 2002; 109: 26\u201333.","DOI":"10.1542\/peds.109.1.26"},{"key":"21368","unstructured":"Utomo MT. Risk factors for birth asphyxia. Folia Medica indonesiana 2011; 47: 211\u2013214."},{"key":"21369","doi-asserted-by":"crossref","unstructured":"Naithani M, Simalti AK. Biochemical markers in perinatal asphyxia. J Nepal Paediatr Soc 2011; 31: 151\u2013156.","DOI":"10.3126\/jnps.v31i2.4155"},{"key":"21370","doi-asserted-by":"crossref","unstructured":"Boskabadi H, Maamouri G, Rezagholizade Omran F, Mafinejad S, Tara F, Rayman MP, et al. Effect of prenatal selenium supplementation on cord blood selenium and lipid profile. Pediatr Neonatol 2012; 53: 334\u2013339.","DOI":"10.1016\/j.pedneo.2012.08.008"},{"key":"21371","unstructured":"Boskabadi H, Maamouri G, Sadeghian MH, GhayourMobarhan M, Heidarzade M, Shakeri MT, et al. Early diagnosis of perinatal asphyxia by nucleated red blood cell count: a case-control study. Arch Iran Med 2010; 13: 275\u2013281."},{"key":"21372","doi-asserted-by":"crossref","unstructured":"S\u00e4vman K, Blennow M, Gustafson K, Tarkowski E, Hagberg H. Cytokine response in CSF after birth asphyxia. PediatrRes 1998; 43: 746\u2013751.","DOI":"10.1203\/00006450-199806000-00006"},{"key":"21373","doi-asserted-by":"crossref","unstructured":"Boskabadi H, Omidian M, Tavallai S, Mohammadi S, Parizadeh M, Ghayour Mobarhan MG, et al. Serum Hsp70 antigen: early diagnosis marker in perinatal asphyxia. Iran J Pediatr 2015; 25: e381.","DOI":"10.5812\/ijp.381"},{"key":"21374","doi-asserted-by":"crossref","unstructured":"Dammann O, Leviton A. Infection remote from the brain, neonatal white matter damage, and cerebral palsy in the preterm infant. Semin Pediatr Neurol 1998; 5: 190\u2013201.","DOI":"10.1016\/S1071-9091(98)80034-X"},{"key":"21375","unstructured":"Okazaki K, Kuboi T, Kusaka T, Kondo M, Kimura H. Pathophysiological roles of cytokines in the brain during perinatal asphyxia. Ann Pediatr Child Health 2015; 3: 1030\u20131039."},{"key":"21376","doi-asserted-by":"crossref","unstructured":"Oppenheim JJ. Cytokines: past, present, and future. Int J Hematol 2001; 74: 3\u20138.","DOI":"10.1007\/BF02982543"},{"key":"21377","doi-asserted-by":"crossref","unstructured":"Dammann O, Leviton A. Maternal intrauterine infection, cytokines, and brain damage in the preterm newborn. Pediatr Res 1997; 42: 1\u20138.","DOI":"10.1203\/00006450-199707000-00001"},{"key":"21378","doi-asserted-by":"crossref","unstructured":"Dihn\u00e9 M, Block F. Focal ischemia induces transient expression of IL-6 in the substantia nigra pars reticulata. Brain Res2001; 889: 165\u2013173.","DOI":"10.1016\/S0006-8993(00)03129-2"},{"key":"21379","doi-asserted-by":"crossref","unstructured":"Chiesa C, Pellegrini G, Panero A, De Luca T, Assumma M, Signore F, et al. Umbilical cord interleukin-6 levels are elevated in term neonates with perinatal asphyxia. Eur J Clin Invest 2003; 33: 352\u2013358.","DOI":"10.1046\/j.1365-2362.2003.01136.x"},{"key":"21380","unstructured":"Paliwal P, Varma M, Mulye S, Paliwal M, Shaikh M. Study of neurological marker in perinatal asphyxia and its correlation with different stages of hypoxic ischemic encephalopathy. Int J Sci Study 2014; 2: 40\u201343."},{"key":"21381","doi-asserted-by":"crossref","unstructured":"Silveira Rde C, Procianoy RS. Levels of interleukin-6 and tumor necrosisfactor-alpha in the CSF of full-term newborns with hypoxic-ischemic encephalopathy. J Pediatr (Rio J) 2003; 79: 297\u2013302.","DOI":"10.2223\/JPED.1047"},{"key":"21382","doi-asserted-by":"crossref","unstructured":"Martin-Ancel A, Garcia-Alix A, Pascual-Salcedo D, Cabanas F, Valcarce M, Quero J. Interleukin-6 inthe CSF after perinatal asphyxia is related to early and late neurological manifestations. Pediatrics 1997; 100:","DOI":"10.1542\/peds.100.5.789"},{"key":"21383","unstructured":"\u2013794."},{"key":"21384","doi-asserted-by":"crossref","unstructured":"Shang Y, Mu L, Guo X, Li Y, Wang L, Yang W, et al. Clinical significance of interleukin-6, tumor necrosis factor- \u03b1 and high-sensitivity C-reactive protein in neonates with hypoxic-ischemic encephalopathy. Exp Ther Med 2014; 8:1259\u20131262.","DOI":"10.3892\/etm.2014.1869"},{"key":"21385","unstructured":"Yi-hong Z, Lan-fen T,Dang A, Zan-cai S, Yu-li J. Relationship of interleukin-6 and insulin-like growth factor1 serumlevels with brain damage in neonatal asphyxia. Journal of Guangdong Medical College 2004; 1: 007."},{"key":"21386","unstructured":"Boskabadi H, Maamouri G, TavakolAfshari J, Shakeri perinatal asphyxia. Iranian Journal of Neonatology 2010; 1: 24\u201329."},{"key":"21387","doi-asserted-by":"crossref","unstructured":"Oyg\u00fcr N, S\u00f6nmez \u00d6, Saka O, Yegin O. Predictive value of plasma and CSF tumour necrosis factor-\u03b1and interleukin1\u03b2 concentrations on outcome of full term infants with hypoxic\u2013ischaemic encephalopathy. Arch Dis Child Fetal Neonatal Ed 1998; 79: F190\u2013F193.","DOI":"10.1136\/fn.79.3.F190"},{"key":"21388","unstructured":"Boskabadi H, Maamouri G, Tavakkol Afshari J, Zakerihamidi M, Kalateh Molaee M, Bagheri F, et al. Combination of Serum interleukin-1\u03b2 and 6 concentrations levels in thediagnosis perinatal asphyxia. Arch Iran Med 2015; 19: 312\u2013316."},{"key":"21389","doi-asserted-by":"crossref","unstructured":"Fotopoulos S, Pavlou K, Skouteli H, Papassotiriou I, Lipsou N, Xanthou M. Early markers of brain damage in premature low-birth-weight neonates who suffered from perinatal asphyxia and\/or infection. Biol Neonate 2001; 79: 213\u2013218.","DOI":"10.1159\/000047094"},{"key":"21390","doi-asserted-by":"crossref","unstructured":"Alsulaimani AA, Abuelsaad ASA, Mohamed NM. Inflammatory cytokines in neonatal hypoxic ischemic encephalopathy and their correlation with brain marker S100 protein: A case control study in Saudi Arabia. J Clin Cell Immunol 2015; 6: 2\u20139.","DOI":"10.4172\/2155-9899.1000289"},{"key":"21391","doi-asserted-by":"crossref","unstructured":"Hagberg H, Gilland E, Bona E, Hanson LA, Hahn-Zoric M, Blennow M, et al. Enhanced expression of interleukin (IL)-1 and IL-6 messenger RNA and bioactive protein after hypoxia-ischemia in neonatal rats. Pediat Res 1996; 40: 603\u2013609.","DOI":"10.1203\/00006450-199610000-00015"},{"key":"21392","doi-asserted-by":"crossref","unstructured":"Selmaj KW, Farooq M, Norton WT, Raine CS, Brosnan CF. Proliferation of astrocytes in vitroin response to cytokines. A primary role for tumor necrosis factor. J Immunol 1990;144: 129\u2013135.","DOI":"10.4049\/jimmunol.144.1.129"},{"key":"21393","doi-asserted-by":"crossref","unstructured":"Kharazmi A, Nielsen H, Rechnitzer C, Bendtzen K. Interleukin 6 primes human neutrophil and monocyte oxidative burst response. Immunol Lett 1989; 21: 177\u2013184.","DOI":"10.1016\/0165-2478(89)90056-4"},{"key":"21394","unstructured":"Aly H, Khashaba MT, El-Ayouty M, El-Sayed O, Hasanein BM. IL-1\u03b2, IL-6 and TNF-\u03b1 and outcomes of neonatal"},{"key":"21395","doi-asserted-by":"crossref","unstructured":"hypoxic ischemic encephalopathy. Brain Dev 2006; 28: 178\u2013182.","DOI":"10.1016\/j.braindev.2005.06.006"},{"key":"21396","doi-asserted-by":"crossref","unstructured":"Shalak LF, Laptook AR, Jafri HS, Ramilo O, Perlman JM. Clinical chorioamnionitis, elevated cytokines, and brain injury in term infants. Pediatrics 2002; 110: 673\u2013680.","DOI":"10.1542\/peds.110.4.673"},{"key":"21397","doi-asserted-by":"crossref","unstructured":"Suzuki S, Tanaka K, Suzuki N. Ambivalent aspects of interleukin-6 in cerebral ischemia: inflammatory versus neurotrophicaspects. J Cereb Blood Flow Metab 2009; 29: 464\u2013479.","DOI":"10.1038\/jcbfm.2008.141"},{"key":"21398","doi-asserted-by":"crossref","unstructured":"Jenkins DD, Rollins LG, Perkel JK, Wagner CL, Katikaneni LP, Bass WT, et al. Serum cytokines in a clinical trial of hypothermia for neonatal hypoxic-ischemic encephalopathy. J Cereb Blood Flow Metab 2012; 32: 1888\u20131896.","DOI":"10.1038\/jcbfm.2012.83"},{"key":"21399","doi-asserted-by":"crossref","unstructured":"Xing Z, Gauldie J, Cox G, Baumann H, Jordana M, Lei XF, et al. IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. J Clin Invest 1998; 101: 311\u2013320.","DOI":"10.1172\/JCI1368"},{"key":"21400","doi-asserted-by":"crossref","unstructured":"Vila N, Castillo J, D\u00e1valos A, Chamorro \u00c1. Proinflammatory cytokines and early neurological worsening in ischemic stroke. Stroke 2000; 31: 2325\u20132329.","DOI":"10.1161\/01.STR.31.10.2325"},{"key":"21401","doi-asserted-by":"crossref","unstructured":"Nelson KB, Grether JK. Causes of cerebral palsy. Curr Opin Pediatr 1999; 11: 487\u2013491.","DOI":"10.1097\/00008480-199912000-00002"},{"key":"21402","doi-asserted-by":"crossref","unstructured":"Matsuda S, Wen TC, Morita F, Otsuka H, Igase K, Yoshimura H, et al. Interleukin-6 prevents ischemia-induced learning disability and neuronal and synaptic loss in gerbils. Neurosci Lett 1996; 204: 109\u2013112.","DOI":"10.1016\/0304-3940(96)12340-5"},{"key":"21403","doi-asserted-by":"crossref","unstructured":"Okazaki K, Nishida A, Kato M, Kozawa K, Uga N, Kimura H. Elevation of cytokine concentrations in asphyxiated neonates. Biol Neonate 2005; 89: 183\u2013189.","DOI":"10.1159\/000089180"},{"key":"21404","doi-asserted-by":"crossref","unstructured":"Yoon BH, Romero R, Park JS, Kim CJ, Kim SH, Choi JH, et al. Fetal exposure to an intra-amniotic inflammation and the development of cerebral palsy at the age of three years. Am J Obstet Gynecol 2000; 182: 675\u2013681.","DOI":"10.1067\/mob.2000.104207"},{"key":"21405","doi-asserted-by":"crossref","unstructured":"Tekgul H, Yalaz M, Kutukculer N, Ozbek S, Kose T, Akisu M, et al. Value of biochemical markers for outcome in term infants with asphyxia. Pediatr Neurol 2004; 31: 326\u2013332.","DOI":"10.1016\/j.pediatrneurol.2004.05.004"},{"key":"21406","doi-asserted-by":"crossref","unstructured":"Liu J, Feng ZC. Increased umbilical cord plasma interleukin-1\u03b2 levels was correlated with adverse outcomes of neonatal hypoxic-ischemic encephalopathy. J Trop Pediatr 2010; 56: 178\u2013182.","DOI":"10.1093\/tropej\/fmp098"},{"key":"21407","doi-asserted-by":"crossref","unstructured":"Oygur N, Sonmez O, Saka O, Yegin O. Predictive values of plasma and CSF TNF and interleukin 1 concentrations on outcome of full term infants with hypoxic ischemic encephalopathy. Arch Dis Child Fetal Neonatal Ed 1998; 79: F190\u2013F193.","DOI":"10.1136\/fn.79.3.F190"},{"key":"21408","doi-asserted-by":"crossref","unstructured":"Martin D, Chinookoswong N, Miller G. The interleukin1 receptor antagonist (rhIL-1ra) protects against cerebral infarction in a rat model of hypoxia-ischemia. Exp Neurol 1994; 130: 362\u2013367.","DOI":"10.1006\/exnr.1994.1215"}],"container-title":["International Journal of Reproductive BioMedicine (IJRM)"],"original-title":[],"link":[{"URL":"https:\/\/knepublishing.com\/index.php\/ijrm\/article\/download\/4598\/9267","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/knepublishing.com\/index.php\/ijrm\/article\/download\/4598\/9270","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/knepublishing.com\/index.php\/ijrm\/article\/download\/4598\/9267","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T11:17:19Z","timestamp":1737717439000},"score":1,"resource":{"primary":{"URL":"https:\/\/knepublishing.com\/index.php\/ijrm\/article\/view\/4598"},"secondary":[{"URL":"http:\/\/journals.ssu.ac.ir\/ijrmnew\/article-1-1514-en.html","label":"UNIVERSITY"},{"URL":"http:\/\/www.knepublishing.com\/index.php\/ijrm\/article\/view\/4598","label":"PUBLISHER"}]},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,18]]},"references-count":51,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2019,6,26]]}},"URL":"https:\/\/doi.org\/10.18502\/ijrm.v17i5.4598","relation":{},"ISSN":["2476-3772","2476-4108"],"issn-type":[{"value":"2476-3772","type":"electronic"},{"value":"2476-4108","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6,18]]},"assertion":[{"value":"2018-06-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-10-06","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-12-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}